Literature DB >> 22155722

Fak depletion in both hematopoietic and nonhematopoietic niche cells leads to hematopoietic stem cell expansion.

Jiayun Lu1, Yan Sun, Cesar Nombela-Arrieta, Karrie P Du, Shin-Young Park, Li Chai, Carl Walkley, Hongbo R Luo, Leslie E Silberstein.   

Abstract

Hematopoietic stem cells (HSCs) reside in complex bone marrow microenvironments, where niche-induced signals regulate hematopoiesis. Focal adhesion kinase (Fak) is a nonreceptor protein tyrosine kinase that plays an essential role in many cell types, where its activation controls adhesion, motility, and survival. Fak expression is relatively increased in HSCs compared to progenitors and mature blood cells. Therefore, we explored its role in HSC homeostasis. We have used the Mx1-Cre-inducible conditional knockout mouse model to investigate the effects of Fak deletion in bone marrow compartments. The total number as well as the fraction of cycling Lin(-)Sca-1(+)c-kit(+) (LSK) cells is increased in Fak(-/-) mice compared to controls, while hematopoietic progenitors and mature blood cells are unaffected. Bone marrow cells from Fak(-/-) mice exhibit enhanced, long-term (i.e., 20-week duration) engraftment in competitive transplantation assays. Intrinsic Fak function was assessed in serial transplantation assays, which showed that HSCs (Lin(-)Sca-1(+)c-kit(+)CD34(-)Flk-2(-) cells) sorted from Fak(-/-) mice have similar self-renewal and engraftment ability on a per-cell basis as wild-type HSCs. When Fak deletion is induced after engraftment of Fak(fl/fl)Mx1-Cre(+) bone marrow cells into wild-type recipient mice, the number of LSKs is unchanged. In conclusion, Fak inactivation does not intrinsically regulate HSC behavior and is not essential for steady-state hematopoiesis. However, widespread Fak inactivation in the hematopoietic system induces an increased and activated HSC pool size, potentially as a result of altered reciprocal interactions between HSCs and their microenvironment. Copyright Â
© 2012 ISEH - Society for Hematology and Stem Cells. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22155722      PMCID: PMC3307834          DOI: 10.1016/j.exphem.2011.11.010

Source DB:  PubMed          Journal:  Exp Hematol        ISSN: 0301-472X            Impact factor:   3.084


  40 in total

Review 1.  Adaptive skeletal responses to mechanical loading during adolescence.

Authors:  David A Greene; Geraldine A Naughton
Journal:  Sports Med       Date:  2006       Impact factor: 11.136

Review 2.  Maintenance of quiescent hematopoietic stem cells in the osteoblastic niche.

Authors:  Fumio Arai; Toshio Suda
Journal:  Ann N Y Acad Sci       Date:  2007-03-01       Impact factor: 5.691

3.  Nuclear FAK promotes cell proliferation and survival through FERM-enhanced p53 degradation.

Authors:  Ssang-Taek Lim; Xiao Lei Chen; Yangmi Lim; Dan A Hanson; Thanh-Trang Vo; Kyle Howerton; Nicholas Larocque; Susan J Fisher; David D Schlaepfer; Dusko Ilic
Journal:  Mol Cell       Date:  2008-01-18       Impact factor: 17.970

Review 4.  Integrin-regulated FAK-Src signaling in normal and cancer cells.

Authors:  Satyajit K Mitra; David D Schlaepfer
Journal:  Curr Opin Cell Biol       Date:  2006-08-17       Impact factor: 8.382

5.  A microenvironment-induced myeloproliferative syndrome caused by retinoic acid receptor gamma deficiency.

Authors:  Carl R Walkley; Gemma Haines Olsen; Sebastian Dworkin; Stewart A Fabb; Jeremy Swann; Grant A McArthur; Susan V Westmoreland; Pierre Chambon; David T Scadden; Louise E Purton
Journal:  Cell       Date:  2007-06-15       Impact factor: 41.582

6.  Roles of focal adhesion kinase (FAK) in megakaryopoiesis and platelet function: studies using a megakaryocyte lineage specific FAK knockout.

Authors:  Ian S Hitchcock; Norma E Fox; Nicolas Prévost; Katherine Sear; Sanford J Shattil; Kenneth Kaushansky
Journal:  Blood       Date:  2007-10-09       Impact factor: 22.113

7.  SOCS3 protein developmentally regulates the chemokine receptor CXCR4-FAK signaling pathway during B lymphopoiesis.

Authors:  Yi Le; Bing-Mei Zhu; Brendan Harley; Shin-Young Park; Takashi Kobayashi; John P Manis; Hongbo R Luo; Akihiko Yoshimura; Lothar Hennighausen; Leslie E Silberstein
Journal:  Immunity       Date:  2007-11       Impact factor: 31.745

8.  Focal adhesion kinase is required for CXCL12-induced chemotactic and pro-adhesive responses in hematopoietic precursor cells.

Authors:  A M Glodek; Y Le; D M Dykxhoorn; S-Y Park; G Mostoslavsky; R Mulligan; J Lieberman; H E Beggs; M Honczarenko; L E Silberstein
Journal:  Leukemia       Date:  2007-06-14       Impact factor: 11.528

9.  Rb regulates interactions between hematopoietic stem cells and their bone marrow microenvironment.

Authors:  Carl R Walkley; Jeremy M Shea; Natalie A Sims; Louise E Purton; Stuart H Orkin
Journal:  Cell       Date:  2007-06-15       Impact factor: 41.582

Review 10.  Stem cells and niches: mechanisms that promote stem cell maintenance throughout life.

Authors:  Sean J Morrison; Allan C Spradling
Journal:  Cell       Date:  2008-02-22       Impact factor: 41.582

View more
  10 in total

1.  Regulation of Stat5 by FAK and PAK1 in Oncogenic FLT3- and KIT-Driven Leukemogenesis.

Authors:  Anindya Chatterjee; Joydeep Ghosh; Baskar Ramdas; Raghuveer Singh Mali; Holly Martin; Michihiro Kobayashi; Sasidhar Vemula; Victor H Canela; Emily R Waskow; Valeria Visconte; Ramon V Tiu; Catherine C Smith; Neil Shah; Kevin D Bunting; H Scott Boswell; Yan Liu; Rebecca J Chan; Reuben Kapur
Journal:  Cell Rep       Date:  2014-11-13       Impact factor: 9.423

2.  Maintenance of hematopoietic stem cell dormancy: yet another role for the macrophage.

Authors:  Karin Gustafsson; Michael Welsh
Journal:  Stem Cell Investig       Date:  2016-09-19

Review 3.  Adhesion in the stem cell niche: biological roles and regulation.

Authors:  Shuyi Chen; Michelle Lewallen; Ting Xie
Journal:  Development       Date:  2013-01-15       Impact factor: 6.868

Review 4.  Mechanobiology of bone marrow stem cells: from myosin-II forces to compliance of matrix and nucleus in cell forms and fates.

Authors:  Jae-Won Shin; Joe Swift; Irena Ivanovska; Kyle R Spinler; Amnon Buxboim; Dennis E Discher
Journal:  Differentiation       Date:  2013-06-19       Impact factor: 3.880

Review 5.  FAK in cancer: mechanistic findings and clinical applications.

Authors:  Florian J Sulzmaier; Christine Jean; David D Schlaepfer
Journal:  Nat Rev Cancer       Date:  2014-08-07       Impact factor: 60.716

6.  Erythroid cells generated in the absence of specific β1-integrin heterodimers accumulate reactive oxygen species at homeostasis and are unable to mount effective antioxidant defenses.

Authors:  Tatyana Ulyanova; Yi Jiang; Steven M Padilla; Thalia Papayannopoulou
Journal:  Haematologica       Date:  2013-06-28       Impact factor: 9.941

7.  Hypoxic niche-mediated regeneration of hematopoiesis in the engraftment window is dominantly affected by oxygen tension in the milieu.

Authors:  Ranjita Devi Moirangthem; Shweta Singh; Ashwini Adsul; Sapana Jalnapurkar; Lalita Limaye; Vaijayanti P Kale
Journal:  Stem Cells Dev       Date:  2015-07-28       Impact factor: 3.272

8.  Feedback signals in myelodysplastic syndromes: increased self-renewal of the malignant clone suppresses normal hematopoiesis.

Authors:  Thomas Walenda; Thomas Stiehl; Hanna Braun; Julia Fröbel; Anthony D Ho; Thomas Schroeder; Tamme W Goecke; Björn Rath; Ulrich Germing; Anna Marciniak-Czochra; Wolfgang Wagner
Journal:  PLoS Comput Biol       Date:  2014-04-24       Impact factor: 4.475

9.  Modeling the Pro-inflammatory Tumor Microenvironment in Acute Lymphoblastic Leukemia Predicts a Breakdown of Hematopoietic-Mesenchymal Communication Networks.

Authors:  Jennifer Enciso; Hector Mayani; Luis Mendoza; Rosana Pelayo
Journal:  Front Physiol       Date:  2016-08-19       Impact factor: 4.566

10.  PTK2 and PTPN11 expression in myelodysplastic syndromes.

Authors:  Mariana Lazarini; João Agostinho Machado-Neto; Leticia Fröhlich Archangelo; Bruna Fernandes Mendes-Silva; Carolina Louzão Bigarella; Fabiola Traina; Sara Teresinha Olalla Saad
Journal:  Clinics (Sao Paulo)       Date:  2013-10       Impact factor: 2.365

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.